FindTrial
Sign In

Diagnostic method using cell free DNA to predict the prognosis of patients with colorectal cancer

Development of an economic biomarker diagnostic method using cell free DNA to predict the prognosis of patients with colorectal cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0005534
Enrollment
20
Registered
2020-10-27
Start date
2020-10-05
Completion date
Unknown
Last updated
2020-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

The Catholic University of Korea, Seoul St. Mary's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with colorectal cancer hospitalized after October 2020 at Seoul St.Mary's Hospital

Exclusion criteria

Exclusion criteria: Two or more concurrent cancer patients ASA score>3

Design outcomes

Primary

MeasureTime frame
Comparative evaluation of the existing cfDNA quantification method based on clinical samples and this method—

Secondary

MeasureTime frame
blood test result—

Countries

Korea, Republic of

Contacts

Public ContactChul Seung Lee

The Catholic University of Korea, Seoul St. Mary's Hospital

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026